vTv Therapeutics
VTVT • NASDAQ • Stock Fundamentals
vTv Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Paul J. Sekhri, with a market cap of $130.6M.
Market Cap$130.6M
Employees16.0
CEOPaul J. Sekhri
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
vTv Therapeutics FAQ
Common questions about vTv Therapeutics
vTv Therapeutics (VTVT) has a market capitalization of $130.6M and trades on NASDAQ.
vTv Therapeutics has approximately 16 employees.